Has been concerned about the precise medical level of market investment sonhwa capital investment director Wang Yang said, in 2017 ~ 2018, the possibility of the existence of the industry reshuffle accurate medical industry. Not just in the mergers and acquisitions of listed companies, will also occur between these startups. This forecast and Zhou Rui agree without prior without previous consultation.

Wang Yang believes that the current number of domestic testing companies more than 600 companies. Most companies got an angel or A round of financing in the past two years the capital boom, but subsequent financing process was tight. The reason is that on the one hand the growth performance and lower profits, ideal is greater than the actual; on the other hand, generally high valuation, then set the strength is weak, the financing is unable to form the effective cohesion. So, the future of some companies may continue to grow through financing for big companies, some may by way of mergers and acquisitions to complete the reorganization of assets.

After non-invasive prenatal genetic testing market broke out, domestic precise medical development and more focus on the field of tumor. But the current domestic (Oncology) several leading (gene sequencing), a few years before the patient to go to a total of detection million cases, the year 4 million 300 thousand new cancer patients, add up all the companies of the total market share is very low. The industry is still in the stage of education market, policy makers, investors, employees, doctors and patients need education.

A stage of capital market before the Blitz and industry development speed does not match, there will be some “bubble” extrusion process. While some companies also have good prospects in the global scope of “buy buy buy” to quickly enhance their strength.

Carbon cloud intelligent by BGI CEO Wang Jun rate team founded, April 2016 A round of financing amount of nearly 1 billion yuan, led by Tencent, then carbon smart cloud also began to use the way of mergers and acquisitions in the medical field, accurate take cities and seize territory”. In September 15, 2016, Israel announced the establishment of smart cloud carbon research center and Israel image understanding and artificial acquisition of a private Intelligent Company ImaguVisionTechnologies.

Another worthy of concern in the industry company is from stocks to complete the delisting of the Wuxi, in recent years through mergers and acquisitions, investment has gradually formed a gene detection, cellular immune therapy, drug CRO and the layout of the whole industry chain, the industry believes that the layout of the future medicine or will have greater value.

In short, whether it is to set up a wholly owned subsidiary or holding shares, mergers and acquisitions, the main mode of listed companies to develop accurate in the medical field, and these new areas can be contributed to the listed company profits, the harvest period may also further reduce the cost of sequencing in Lai, sensitivity of the further development of technology after judgment.